Unveiling the Potential of RN7SL455P as a Drug Target or Biomarker
Unveiling the Potential of RN7SL455P as a Drug Target or Biomarker
Introduction
The RNA-protein complex, composed of RNA and protein molecules, plays a crucial role in various cellular processes. One of the well-known RNA-protein interactions is the cytoplasmic 455-like structure (c455), which has been observed in various organisms . RN7SL455P, a specific RNA molecule, has been identified as a potential drug target or biomarker, and its functional implications have been explored in this article.
RNA Structure and Function
RN7SL455P is a 21-nucleotide RNA molecule with a unique 7-slice structure. It contains a single exon that encodes the protein coding gene (1-segment), but with an additional exon that does not code for any protein. The 7-slice The structure consists of a core-like region, which encodes the 5'-end of the RNA, and six exonic regions that encode the 3'-end of the RNA.
RN7SL455P has been shown to have various cellular processes involved in its structure and function. Firstly, it is involved in the regulation of gene expression. Studies have shown that RN7SL455P can act as a scaffold to recruit various RNA-protein interactions, including those with known protein-protein interaction modules, such as the nucleosome and the nucleolus. Secondly, RN7SL455P is associated with various cellular signaling pathways, including the regulation of cell growth, apoptosis, and inflammation.
Potential Drug Target
The unique 7-slice structure of RN7SL455P makes it an attractive drug target. The protein coding region has multiple potential druggable residues, including a conserved G/C-rich region, a lysine residue, and a Glu-rich region. Chemical inhibitors have been shown to interact with these residues and alter the stability of the RNA molecule. Therefore, RN7SL455P may be a suitable target for small molecules or antibodies that can modulate its stability or activity.
In addition to its potential drug target, RN7SL455P also has the potential to serve as a biomarker. The cytoplasmic 455-like structure is a well-established biomarker for various diseases, including cancer, neurodegenerative diseases, and genetic disorders. The detection and quantification of the c455-like structure can provide valuable information about the levels of disease-related RNAs in the cell, which may be used to diagnose or monitor the disease.
Conclusion
In conclusion, RN7SL455P is a unique RNA molecule with various cellular processes involved in its structure and function. Its 7-slice structure and unique protein coding region make it an attractive drug target or biomarker. Further studies are needed to explore its drug potential targeting and diagnostic applications.
Protein Name: RNA, 7SL, Cytoplasmic 455, Pseudogene
More Common Targets
RN7SL471P | RN7SL491P | RN7SL4P | RN7SL517P | RN7SL519P | RN7SL546P | RN7SL552P | RN7SL555P | RN7SL573P | RN7SL5P | RN7SL600P | RN7SL610P | RN7SL636P | RN7SL665P | RN7SL674P | RN7SL679P | RN7SL68P | RN7SL691P | RN7SL748P | RN7SL750P | RN7SL752P | RN7SL767P | RN7SL783P | RN7SL791P | RN7SL865P | RN7SL868P | RN7SL87P | RN7SL8P | RNA Polymerase I Complex | RNA polymerase II complex | RNA polymerase II elongator complex | RNA polymerase III (Pol III) complex | RNA-induced silencing complex | RNA18SN5 | RNA28SN5 | RNA45SN5 | RNA5-8SN1 | RNA5-8SN5 | RNA5-8SP2 | RNA5-8SP4 | RNA5-8SP6 | RNA5S1 | RNA5S10 | RNA5S11 | RNA5S12 | RNA5S17 | RNA5S2 | RNA5S3 | RNA5S4 | RNA5S9 | RNA5SP111 | RNA5SP115 | RNA5SP116 | RNA5SP129 | RNA5SP151 | RNA5SP162 | RNA5SP165 | RNA5SP174 | RNA5SP175 | RNA5SP178 | RNA5SP18 | RNA5SP180 | RNA5SP183 | RNA5SP185 | RNA5SP187 | RNA5SP19 | RNA5SP194 | RNA5SP195 | RNA5SP196 | RNA5SP197 | RNA5SP20 | RNA5SP201 | RNA5SP205 | RNA5SP207 | RNA5SP217 | RNA5SP233 | RNA5SP236 | RNA5SP242 | RNA5SP268 | RNA5SP282 | RNA5SP284 | RNA5SP318 | RNA5SP323 | RNA5SP329 | RNA5SP33 | RNA5SP335 | RNA5SP339 | RNA5SP343 | RNA5SP344 | RNA5SP345 | RNA5SP352 | RNA5SP353 | RNA5SP363 | RNA5SP371 | RNA5SP374 | RNA5SP378 | RNA5SP379 | RNA5SP385 | RNA5SP389 | RNA5SP390